
  
    
      
        Introduction_NNP
        The_DT epithelial_NN component_NN of_IN normal_JJ and_CC non-invasive_JJ
        breast_NN tissues_NNS is_VBZ normally_RB surrounded_VBN by_IN a_DT layer_NN of_IN
        myoepithelial_NN (_( ME_NNP )_) cells_NNS ,_, whose_WP$ absence_NN or_CC disruption_NN is_VBZ an_DT
        absolute_JJ prerequisite_NN for_IN tumor_NN invasion_NN and_CC metastasis_NNS [_NN 1_CD
        ]_NN ._. ME_NNP cells_NNS are_VBP not_RB easily_RB identifiable_JJ in_IN
        hematoxylin_NN /_NN eosin_NN (_( H_NNP &_CC E_NNP )_) -_: stained_JJ breast_NN tissue_NN sections_NNS ,_,
        as_IN they_PRP are_VBP often_RB indistinguishable_JJ from_IN subjacent_NN
        myofibroblastic_JJ cells_NNS in_IN the_DT stroma_NN ._. Immunohistochemical_NNP
        staining_VBG for_IN smooth_JJ muscle_NN actin_NN (_( SMA_NNP )_) has_VBZ been_VBN routinely_RB
        used_VBN to_TO assist_VB in_IN the_DT identification_NN of_IN ME_NNP cells_NNS [_NN 2_CD ]_NN ._.
        However_RB ,_, we_PRP and_CC others_NNS have_VBP repeatedly_RB noted_VBN that_IN about_IN
        4_CD -_: 6_CD %_NN of_IN morphologically_RB recognizable_JJ ME_NNP cells_NNS in_IN
        H_NNP &_CC E-_NNP stained_JJ sections_NNS fail_VBP to_TO display_VB SMA_NNP
        immunoreactivity_NN [_NN 3_CD 4_CD ]_NN ._. We_PRP attempted_VBD to_TO assess_VB whether_IN
        these_DT SMA-negative_NNP cells_NNS also_RB lack_VBP the_DT expression_NN of_IN eight_CD
        additional_JJ markers_NNS that_WDT are_VBP supposed_VBN to_TO present_VB exclusively_RB
        or_CC preferentially_RB at_IN ME_NNP cells_NNS ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Case_NN selection_NN
          Formalin-fixed_NNP ,_, paraffin-embedded_JJ tissue_NN blocks_NNS from_IN
          female_JJ patients_NNS with_IN breast_NN lesions_NNS were_VBD retrieved_VBN from_IN
          files_NNS of_IN the_DT Armed_NNP Forces_NNP Institute_NNP of_IN Pathology_NNP ._.
          Consecutive_NNP sections_NNS at_IN 4_CD -_: 5_CD μm_NN thickness_NN were_VBD cut_VBN and_CC
          placed_VBN on_IN positively_RB charged_VBN microscopic_JJ slides_NNS ._. A_DT total_NN
          of_IN 175_CD cases_NNS with_IN distinct_JJ ME_NNP cells_NNS ,_, defined_VBN as_IN a_DT
          continuous_JJ layer_NN of_IN spindle-_NN or_CC cuboid-shaped_JJ cells_NNS that_WDT
          overlie_NN the_DT basement_NN membrane_NN and_CC encircle_NN epithelial_NN
          cells_NNS ,_, were_VBD selected_VBN for_IN this_DT study_NN ._. Among_IN the_DT 175_CD cases_NNS ,_,
          all_DT contained_VBD non-invasive_JJ lesions_NNS ,_, including_VBG ductal_NN and_CC
          lobular_NN carcinoma_NN 
          in_IN situ_NN and_CC sclerosing_VBG adenosis_NNS ,_,
          and_CC a_DT few_JJ cases_NNS had_VBD invasive_JJ components_NNS ._.
        
        
          Markers_NNP and_CC reagents_NNS
          Nine_CD antibodies_NNS reported_VBD to_TO present_VB exclusively_RB or_CC
          preferentially_RB at_IN ME_NNP cells_NNS were_VBD selected_VBN for_IN this_DT study_NN [_NN
          5_CD 6_CD 7_CD 8_CD 9_CD 10_CD 11_CD 12_CD 13_CD 14_CD 15_CD 16_CD 17_CD 18_CD 19_CD 20_CD 21_CD 22_CD 23_CD 24_CD 25_CD
          ]_NN (_( Table_NNP 1_LS )_) ;_: these_DT included_VBD antibodies_NNS against_IN SMA_NNP ,_,
          smooth_JJ muscle_NN myosin_NN heavy_JJ chain_NN (_( SM-MHC_NNP )_) ,_, CD_NNP 10_CD ,_,
          calponin_NN ,_, protease_NN inhibitor_NN 5_CD (_( maspin_NN )_) ,_, Wilms_NNP '_POS tumor-_NN 1_CD
          (_( WT-_NNP 1_LS )_) ,_, and_CC cytokeratins_NNS 5_CD ,_, 14_CD ,_, and_CC 17_CD (_( CK_NNP 5_CD ,_, CK_NNP 4_CD ,_, and_CC
          CK_NNP 17_CD )_) ._. Other_JJ reagents_NNS ,_, including_VBG the_DT secondary_JJ antibody_NN ,_,
          detection_NN kits_NNS ,_, and_CC chromogen_NN kits_NNS ,_, were_VBD purchased_VBN from_IN
          Vector_NNP Laboratories_NNPS ,_, Inc_NNP (_( Burlingame_NNP ,_, CA_NNP )_) ._. Digestion_NNP
          enzymes_NNS recommended_VBD for_IN antigen_NN retrieval_NN were_VBD bought_VBN
          from_IN Sigma_NNP (_( St_NNP Louis_NNP ,_, MO_NNP )_) ._. A_DT microwave_NN oven_NN and_CC pressure_NN
          cooker_NN designated_VBN for_IN antigen_NN retrieval_NN ,_, along_IN with_IN
          retrieval_NN solutions_NNS ,_, were_VBD purchased_VBN from_IN Biocare_NNP Medical_NNP
          (_( Walnut_NNP Creek_NNP ,_, CA_NNP )_) ._.
        
        
          Immunohistochemical_NNP staining_VBG
          A_DT preliminary_JJ study_NN was_VBD performed_VBN to_TO optimize_NN the_DT
          immunostaining_VBG condition_NN for_IN all_DT antibodies_NNS selected_VBN ._.
          First_LS ,_, each_DT of_IN the_DT nine_CD antibodies_NNS was_VBD tested_VBN strictly_RB in_IN
          accordance_NN with_IN the_DT manufacturer_NN 's_POS recommended_VBD protocol_NN ,_,
          including_VBG the_DT methods_NNS of_IN antigen_NN retrieval_NN and_CC the_DT length_NN
          of_IN the_DT primary_JJ antibody_NN incubation_NN time_NN ._. Then_RB ,_, each_DT
          antibody_NN was_VBD tested_VBN with_IN our_PRP$ published_VBN protocol_NN ,_, which_WDT
          involves_VBZ an_DT overnight_JJ incubation_NN of_IN deparaffinized_JJ
          sections_NNS at_IN 70_CD °_NN C_NNP in_IN the_DT retrieval_NN solution_NN and_CC an_DT
          incubation_NN for_IN 3_CD -_: 4_CD hours_NNS or_CC overnight_JJ of_IN the_DT primary_JJ
          antibody_NN at_IN about_IN 25_CD °_NN C_NNP [_NN 26_CD ]_NN ._. Two_CD adjacent_JJ sections_NNS
          stained_JJ by_IN using_VBG our_PRP$ protocol_NN and_CC the_DT manufacturer_NN 's_POS
          recommended_VBD protocols_NNS were_VBD compared_VBN for_IN specificity_NN and_CC
          sensitivity_NN ._. As_IN our_PRP$ protocol_NN consistently_RB yielded_VBD
          stronger_JJR and_CC more_RBR distinct_JJ staining_VBG for_IN all_PDT the_DT
          antibodies_NNS ,_, the_DT final_JJ staining_VBG for_IN all_PDT the_DT 175_CD cases_NNS with_IN
          SMA_NNP and_CC a_DT double_JJ immunostaining_VBG with_IN additional_JJ markers_NNS
          in_IN selected_VBN cases_NNS (_( see_VB below_IN )_) were_VBD performed_VBN with_IN our_PRP$
          published_VBN protocol_NN [_NN 26_CD ]_NN ._.
        
        
          Double_RB immunohistochemical_JJ staining_VBG
          All_DT H_NNP &_CC E-_NNP stained_JJ and_CC immunostained_JJ sections_NNS were_VBD
          reviewed_VBN independently_RB by_IN at_IN least_JJS two_CD investigators_NNS ._. All_DT
          ducts_NNS lined_VBN by_IN at_IN least_JJS 50_CD epithelial_NN cells_NNS were_VBD
          examined_VBN ,_, and_CC three_CD cases_NNS were_VBD found_VBN to_TO contain_VB ducts_NNS
          that_WDT displayed_VBD morphologically_RB distinct_JJ ME_NNP cell_NN layers_NNS in_IN
          H_NNP &_CC E-_NNP stained_JJ sections_NNS ,_, but_CC ME_NNP cells_NNS in_IN at_IN least_JJS
          one-third_NN of_IN the_DT layer_NN or_CC the_DT entire_JJ layer_NN were_VBD devoid_JJ of_IN
          SMA_NNP staining_VBG ._. Eight_CD consecutive_JJ sections_NNS from_IN each_DT of_IN the_DT
          three_CD selected_VBN cases_NNS were_VBD used_VBN for_IN a_DT double_JJ
          immunostaining_VBG with_IN our_PRP$ published_VBN protocols_NNS [_NN 26_CD 27_CD ]_NN ._.
          In_IN brief_JJ ,_, all_DT eight_CD sections_NNS were_VBD first_JJ immunostained_JJ for_IN
          SMA_NNP with_IN a_DT black_JJ chromogen_NN ._. Each_DT section_NN was_VBD then_RB stained_JJ
          for_IN one_CD of_IN the_DT eight_CD additional_JJ ME_NNP markers_NNS with_IN a_DT red_JJ
          chromogen_NN ._. The_DT same_JJ ducts_NNS with_IN SMA-negative_NNP ME_NNP cells_NNS were_VBD
          examined_VBN for_IN the_DT expression_NN of_IN other_JJ markers_NNS ._. In_IN
          addition_NN ,_, sections_NNS from_IN all_DT three_CD cases_NNS were_VBD
          immunostained_JJ for_IN estrogen_NN receptor_NN (_( ER_NNP )_) and_CC CK_NNP 8_CD to_TO
          exclude_VB the_DT possibility_NN that_IN these_DT SMA-negative_NNP cells_NNS
          might_MD be_VB epithelial_NN in_IN nature_NN ._.
        
      
      
        Results_NNS and_CC discussion_NN
        Results_NNS showed_VBD that_IN all_DT three_CD cases_NNS spanned_VBD a_DT
        morphologic_JJ spectrum_NN ranging_VBG from_IN columnar_NN cell_NN hyperplasia_NN
        to_TO ductal_NN carcinoma_NN 
        in_IN situ_NN ._. Case_NNP 1_CD (_( columnar_NN cell_NN
        hyperplasia_NN )_) contained_VBD two_CD ducts_NNS of_IN interest_NN lined_VBN by_IN about_IN
        500_CD epithelial_NN cells_NNS surrounded_VBN by_IN morphologically_RB distinct_JJ
        ME_NNP cell_NN layers_NNS on_IN the_DT H_NNP &_CC E-_NNP stained_JJ section_NN (_( Fig_NNP ._. 1_LS a_DT )_) ._.
        The_DT ME_NNP cells_NNS in_IN about_IN two-thirds_NNS of_IN the_DT ME_NNP layer_NN showed_VBD
        distinct_JJ and_CC strong_JJ SMA_NNP immunostaining_VBG ,_, whereas_IN the_DT cells_NNS
        in_IN about_IN one-third_NN of_IN the_DT layer_NN were_VBD devoid_JJ of_IN SMA_NNP
        immunostaining_VBG (_( Fig_NNP ._. 1_LS b_SYM )_) ._. The_DT SMA-positive_NNP and_CC SMA-negative_NNP
        cells_NNS were_VBD morphologically_RB indistinguishable_JJ on_IN
        H_NNP &_CC E-_NNP stained_JJ sections_NNS ._. In_IN double_JJ immunostained_JJ sections_NNS ,_,
        these_DT SMA-negative_NNP cells_NNS were_VBD also_RB negative_JJ for_IN SM-MHC_NNP ,_,
        WT-_NNP 1_CD ,_, CD_NNP 10_CD ,_, and_CC calponin_NN (_( Fig_NNP ._. 1_LS c_SYM ,_, 1_CD d_SYM ,_, 1_CD e_SYM ,_, 1_CD f_SYM )_) ._. However_RB ,_, these_DT
        SMA-negative_NNP cells_NNS were_VBD positive_JJ for_IN maspin_NN ,_, CK_NNP 5_CD ,_, CK_NNP 14_CD ,_, and_CC
        CK_NNP 17_CD (_( Fig_NNP ._. 1_LS g_SYM ,_, 1_CD h_NN ,_, 1_CD i_NNP ,_, 1_CD j_NN )_) ._.
        Cases_NNS 2_CD and_CC 3_CD contained_VBD ductal_NN carcinoma_NN 
        in_IN situ_NN ,_, of_IN intermediate_JJ grade_NN and_CC
        low_JJ grade_NN ,_, respectively_RB ._. The_DT ducts_NNS were_VBD surrounded_VBN by_IN
        morphologically_RB distinct_JJ ME_NNP cell_NN layers_NNS in_IN H_NNP &_CC E-_NNP stained_JJ
        sections_NNS (_( Fig_NNP ._. 2_LS a_DT )_) ._. These_DT ME_NNP cell_NN layers_NNS were_VBD attenuated_JJ ,_,
        consisting_VBG of_IN elongated_JJ spindle_NN cells_NNS with_IN dark_JJ and_CC
        compressed_VBN nuclei_NN ._. The_DT entire_JJ ME_NNP cell_NN layer_NN was_VBD devoid_JJ of_IN
        SMA_NNP immunostaining_VBG (_( Fig_NNP ._. 2_LS b_SYM )_) ._. In_IN double_JJ immunostained_JJ
        sections_NNS ,_, these_DT SMA-negative_NNP cells_NNS were_VBD also_RB devoid_JJ of_IN
        distinct_JJ immunostaining_VBG for_IN any_DT of_IN the_DT additional_JJ eight_CD
        markers_NNS (_( Fig_NNP ._. 2_LS c_SYM ,_, 2_CD d_SYM ,_, 2_CD e_SYM ,_, 2_CD f_SYM )_) ._.
        The_DT SMA-negative_NNP cells_NNS in_IN all_DT three_CD cases_NNS showed_VBD
        distinct_JJ negativity_NN to_TO ER_NNP and_CC CK_NNP 8_CD ,_, in_IN sharp_JJ contrast_NN with_IN
        the_DT overlying_VBG epithelial_NN cells_NNS that_WDT showed_VBD strong_JJ ER_NNP and_CC
        CK_NNP 8_CD positivities_NNS (_( data_NNS not_RB shown_VBN )_) ._. The_DT distribution_NN of_IN
        these_DT SMA-negative_NNP ME_NNP cells_NNS seemed_VBD to_TO be_VB independent_JJ of_IN the_DT
        ductal_NN size_NN ,_, length_NN ,_, and_CC architecture_NN ._.
        Our_PRP$ findings_NNS are_VBP consistent_JJ with_IN those_DT of_IN a_DT recent_JJ study_NN
        showing_VBG that_IN a_DT vast_JJ majority_NN of_IN the_DT ME_NNP cells_NNS in_IN both_DT normal_JJ
        and_CC ductal_NN carcinoma_NN 
        in_IN situ_NN displayed_VBD distinct_JJ
        immunostaining_VBG to_TO p_NN 63_CD ,_, SM-MHC_NNP ,_, and_CC calponin_NN ,_, whereas_IN a_DT
        single_JJ or_CC a_DT cluster_NN of_IN a_DT few_JJ ME_NNP cells_NNS in_IN some_DT ducts_NNS failed_VBD
        to_TO show_VB immunoreactivity_NN to_TO all_DT these_DT three_CD markers_NNS [_NN 28_CD ]_NN
        ._. However_RB ,_, our_PRP$ study_NN differs_VBZ from_IN this_DT study_NN [_NN 28_CD ]_NN and_CC
        previous_JJ studies_NNS [_NN 3_CD 4_CD ]_NN in_IN four_CD aspects_NNS :_: first_JJ ,_, the_DT
        SMA-negative_NNP cells_NNS were_VBD segmented_JJ ,_, accounting_NN for_IN at_IN least_JJS
        one-third_NN or_CC all_DT of_IN the_DT ME_NNP cells_NNS in_IN involved_VBN ducts_NNS ;_: second_JJ ,_,
        we_PRP tested_VBD for_IN more_JJR ME_NNP cell_NN markers_NNS ;_: third_JJ ,_, the_DT SMA-negative_NNP
        cells_NNS assessed_VBN were_VBD morphologically_RB similar_JJ to_TO their_PRP$
        adjacent_JJ SMA-positive_NNP neighbors_NNS on_IN H_NNP &_CC E-_NNP stained_JJ
        sections_NNS ;_: fourth_JJ ,_, our_PRP$ focus_NN is_VBZ directed_VBN toward_IN the_DT
        elucidation_NN of_IN the_DT detailed_VBN immunohistochemical_JJ profile_NN of_IN
        these_DT SMA-negative_NNP cells_NNS identified_VBN in_IN 3_CD of_IN 175_CD examined_VBD
        cases_NNS ._. The_DT distribution_NN of_IN different_JJ ME_NNP markers_NNS among_IN
        normal_JJ ,_, benign_JJ ,_, and_CC malignant_JJ breast_NN lesions_NNS in_IN the_DT
        remaining_VBG cases_NNS will_MD be_VB presented_VBN separately_RB ._. In_IN our_PRP$ study_NN ,_,
        p_NN 63_CD was_VBD replaced_VBN with_IN WT-_NNP 1_CD for_IN three_CD main_JJ reasons_NNS :_: first_JJ ,_,
        p_NN 63_CD is_VBZ a_DT nuclear_JJ protein_NN ,_, which_WDT is_VBZ not_RB easily_RB identifiable_JJ
        in_IN attenuated_JJ or_CC compressed_VBN ME_NNP cells_NNS ;_: second_JJ ,_, previous_JJ
        studies_NNS have_VBP shown_VBN that_IN this_DT protein_NN is_VBZ also_RB expressed_VBN in_IN
        ME-cell-derived_NNP neoplasms_NNS and_CC tumors_NNS with_IN squamous_JJ cell_NN
        differentiation_NN [_NN 29_CD ]_NN ;_: third_JJ ,_, our_PRP$ preliminary_JJ study_NN had_VBD
        showed_VBN that_IN WT-_NNP 1_CD had_VBD the_DT same_JJ subcellular_NN localization_NN but_CC
        seemed_VBD to_TO be_VB more_RBR specific_JJ for_IN ME_NNP cells_NNS ,_, compared_VBN with_IN p_NN 63_CD
        [_NN 12_CD ]_NN ._.
        The_DT mechanism_NN of_IN the_DT loss_NN of_IN myoepithelial_NN markers_NNS in_IN
        some_DT of_IN the_DT ME_NNP cells_NNS is_VBZ unknown_JJ ,_, but_CC could_MD result_VB from_IN the_DT
        dynamic_JJ and_CC reciprocal_JJ interactions_NNS between_IN epithelial_NN and_CC
        ME_NNP cells_NNS ._. It_PRP has_VBZ been_VBN documented_VBN that_IN a_DT variety_NN of_IN
        proteolytic_JJ enzymes_NNS produced_VBN by_IN malignant_JJ epithelial_NN cells_NNS
        could_MD have_VB substantial_JJ impacts_NNS on_IN the_DT physical_JJ integrity_NN or_CC
        functions_NNS of_IN the_DT subjacent_NN ME_NNP cells_NNS and_CC the_DT basement_NN
        membrane_NN [_NN 30_CD 31_CD 32_CD ]_NN ._. In_IN contrast_NN ,_, ME_NNP cells_NNS could_MD
        influence_VB the_DT biological_JJ behavior_NN of_IN subjacent_NN epithelial_NN
        cells_NNS ._. Our_PRP$ recent_JJ studies_NNS have_VBP revealed_VBN the_DT co-localization_JJ
        of_IN maspin_NN and_CC WT-_NNP 1_CD exclusively_RB in_IN mammary_JJ ME_NNP cells_NNS [_NN 12_CD ]_NN ._.
        In_IN a_DT vast_JJ majority_NN of_IN cases_NNS ,_, the_DT expression_NN of_IN these_DT two_CD
        proteins_NNS decreases_NNS linearly_RB with_IN tumor_NN progression_NN ,_, and_CC the_DT
        loss_NN of_IN these_DT proteins_NNS or_CC focal_JJ disruptions_NNS in_IN the_DT ME_NNP cell_NN
        layers_NNS leads_VBZ to_TO a_DT significantly_RB higher_JJR cell_NN proliferation_NN
        in_IN the_DT subjacent_NN epithelial_NN cells_NNS [_NN 12_CD 33_CD ]_NN ._. In_IN addition_NN ,_,
        these_DT changes_NNS in_IN ME_NNP cells_NNS could_MD result_VB from_IN effects_NNS of_IN
        certain_JJ chemical_NN compounds_NNS ._.
        It_PRP has_VBZ been_VBN reported_VBN that_IN the_DT exposure_NN to_TO
        lambdacarrageenan_NN could_MD specifically_RB result_VB in_IN filament_NN
        disassembly_RB and_CC loss_NN of_IN ME_NNP cells_NNS [_NN 34_CD ]_NN ._. In_IN contrast_NN ,_,
        exposure_NN to_TO oxytocin_NN could_MD substantially_RB enhance_VB ME_NNP cell_NN
        differentiation_NN and_CC proliferation_NN in_IN mouse_NN breasts_NNS [_NN 35_CD ]_NN ._.
        In_IN addition_NN ,_, these_DT SMA-negative_NNP ME_NNP cells_NNS might_MD be_VB newly_RB
        formed_VBN through_IN stem-cell-mediated_JJ proliferation_NN and_CC are_VBP in_IN
        the_DT transition_NN to_TO a_DT terminally_RB differentiated_JJ status_NN ._. Our_PRP$
        previous_JJ studies_NNS on_IN animal_NN models_NNS have_VBP shown_VBN that_IN
        intercalated_JJ duct_NN cells_NNS in_IN adult_NN rat_NN submandibular_NN glands_NNS
        are_VBP the_DT common_JJ progenitor_NN for_IN both_DT the_DT acinar_NN and_CC granular_JJ
        duct_NN cells_NNS [_NN 27_CD 36_CD ]_NN ._. A_DT recent_JJ study_NN in_IN human_JJ breast_NN has_VBZ
        revealed_VBN that_IN CK_NNP 5_CD -_: positive_JJ cells_NNS are_VBP capable_JJ of_IN giving_VBG rise_NN
        to_TO both_DT glandular_NN and_CC ME_NNP cell_NN lineages_NNS [_NN 21_CD ]_NN ._. In_IN both_DT
        cases_VBZ the_DT intermediate_JJ cells_NNS showed_VBD an_DT unusual_JJ
        immunostaining_VBG pattern_NN for_IN several_JJ proteins_NNS [_NN 21_CD 36_CD ]_NN ._.
        The_DT total_JJ loss_NN of_IN all_DT nine_CD ME_NNP cell_NN immunophenotypic_JJ
        markers_NNS suggests_VBZ that_IN these_DT ME_NNP cells_NNS have_VBP genetic_JJ and_CC
        biochemical_JJ properties_NNS differing_VBG from_IN their_PRP$ SMA-positive_NNP
        counterparts_NNS ._. The_DT significance_NN and_CC consequence_NN of_IN these_DT
        changes_NNS in_IN ME_NNP cells_NNS are_VBP unknown_JJ ._. However_RB ,_, given_VBN that_IN the_DT
        disruption_NN of_IN the_DT ME_NNP cell_NN layer_NN and_CC basement_NN membrane_NN is_VBZ an_DT
        absolute_JJ prerequisite_NN for_IN tumor_NN invasion_NN and_CC metastasis_NNS ,_,
        these_DT alterations_NNS in_IN ME_NNP cells_NNS might_MD affect_VB the_DT biological_JJ
        behavior_NN of_IN the_DT epithelial_NN cells_NNS ,_, making_VBG them_PRP prone_JJ to_TO
        progression_NN ._. Our_PRP$ assumption_NN is_VBZ in_IN agreement_NN with_IN our_PRP$
        previous_JJ findings_NNS ,_, which_WDT have_VBP revealed_VBN that_IN focal_JJ
        disruptions_NNS of_IN ME_NNP cell_NN layers_NNS could_MD lead_VB to_TO a_DT significantly_RB
        higher_JJR proliferation_NN rate_NN in_IN subjacent_NN epithelial_NN cells_NNS [_NN
        12_CD 33_CD ]_NN ._. Our_PRP$ assumption_NN is_VBZ also_RB supported_VBN by_IN a_DT recent_JJ
        study_NN showing_VBG that_IN normal_JJ and_CC tumor-derived_JJ ME_NNP cells_NNS differ_VBP
        substantially_RB in_IN their_PRP$ ability_NN to_TO interact_NN with_IN luminal_NN
        breast_NN epithelial_NN cells_NNS for_IN polarity_NN and_CC basement_NN membrane_NN
        deposition_NN [_NN 37_CD ]_NN ._. Further_RB studies_VBZ are_VBP currently_RB in_IN
        progress_NN to_TO elucidate_NN the_DT biological_JJ behavior_NN and_CC genetic_JJ
        profile_NN of_IN epithelial_NN cells_NNS immediately_RB subjacent_NN to_TO these_DT
        SMA-negative_NNP ME_NNP cells_NNS ._.
      
      
        Conclusions_NNP
        A_DT subset_NN of_IN morphologically_RB identifiable_JJ ME_NNP cells_NNS lacks_VBZ
        the_DT expression_NN of_IN nine_CD corresponding_JJ immunophenotypic_JJ
        markers_NNS ,_, suggesting_VBG that_IN ,_, like_IN the_DT epithelial_NN cells_NNS ,_, ME_NNP
        cells_NNS might_MD also_RB be_VB subject_JJ to_TO different_JJ normal_JJ and_CC
        pathological_JJ alterations_NNS ,_, and_CC that_IN alterations_NNS in_IN ME_NNP cells_NNS
        might_MD significantly_RB affect_VB the_DT functions_NNS and_CC biological_JJ
        behavior_NN of_IN the_DT adjacent_JJ epithelial_NN cells_NNS ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Abbreviations_NNP
        CK_NNP =_SYM cytokeratin_NN ;_: ER_NNP =_SYM estrogen_NN receptor_NN ;_: H_NNP &_CC E_NNP =_SYM
        hematoxylin_NN /_NN eosin_NN ;_: ME_NNP =_SYM myoepithelial_NN ;_: SMA_NNP =_SYM smooth_JJ muscle_NN
        actin_NN ;_: SM-MHC_NNP =_SYM smooth_JJ muscle_NN myosin_NN heavy_JJ chain_NN ;_: WT-_NNP 1_CD =_SYM
        Wilms_NNP '_POS tumor-_NN 1_CD ._.
      
    
  
